# Combination Chemotherapy Before Surgery in Treating Patients With Mesothelioma of the Lung

> **NCT00030745** · PHASE2 · COMPLETED · sponsor: **Swiss Cancer Institute** · enrollment: 61 (actual)

## Conditions studied

- Malignant Mesothelioma

## Interventions

- **DRUG:** cisplatin
- **DRUG:** gemcitabine hydrochloride
- **PROCEDURE:** conventional surgery

## Key facts

- **NCT ID:** NCT00030745
- **Lead sponsor:** Swiss Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-06
- **Primary completion:** 2003-05
- **Final completion:** 2003-08
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2012-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00030745

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00030745, "Combination Chemotherapy Before Surgery in Treating Patients With Mesothelioma of the Lung". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00030745. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*